Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
Expert Review of Respiratory Medicine
|
May 19, 2010
Pharmacology, clinical efficacy and safety of recombinant human DNase in cystic fibrosis
E M Bakker, H A W M Tiddens
The European Respiratory Journal
|
May 28, 2002
Annual lung function changes in young patients with chronic lung disease
P J F M Merkus, H A W M Tiddens, J C de Jongste
Thorax
|
August 7, 2007
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
P M Gustafsson, P A De Jong, H A W M Tiddens, et al.
The Lancet. Respiratory Medicine
|
March 5, 2026
Assessing the reversibility of bronchiectasis with deep learning - Authors' reply
Isabelle Sermet-Gaudelus, Daan Caudri, Punit Makani, et al.
British Journal of Clinical Pharmacology
|
April 19, 2007
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size
J E Esposito-Festen, P Zanen, H A W M Tiddens, et al.
The European Respiratory Journal
|
June 29, 2007
Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
L J van der Giessen, R Gosselink, W C J Hop, et al.
Journal of Theoretical Biology
|
March 10, 2015
Model of mucociliary clearance in cystic fibrosis lungs
P Kurbatova, N Bessonov, V Volpert, et al.
European Journal of Medical Genetics
|
January 4, 2011
Lung disease in FLNA mutation: confirmatory report
M C Y de Wit, H A W M Tiddens, I F M de Coo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 24, 2012
Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency
E M Bakker, J C van der Meijden, E M Nieuwhof, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 24, 2006
[Fatal asthma in childhod preventable by recognizing risk factors and presenting features]
S C A T Verbruggen, L J A Corel, H A W M Tiddens, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
Expert Review of Respiratory Medicine
|
May 19, 2010
Pharmacology, clinical efficacy and safety of recombinant human DNase in cystic fibrosis
E M Bakker, H A W M Tiddens
The European Respiratory Journal
|
May 28, 2002
Annual lung function changes in young patients with chronic lung disease
P J F M Merkus, H A W M Tiddens, J C de Jongste
Thorax
|
August 7, 2007
Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis
P M Gustafsson, P A De Jong, H A W M Tiddens, et al.
The Lancet. Respiratory Medicine
|
March 5, 2026
Assessing the reversibility of bronchiectasis with deep learning - Authors' reply
Isabelle Sermet-Gaudelus, Daan Caudri, Punit Makani, et al.
British Journal of Clinical Pharmacology
|
April 19, 2007
Pharmacokinetics of inhaled monodisperse beclomethasone as a function of particle size
J E Esposito-Festen, P Zanen, H A W M Tiddens, et al.
The European Respiratory Journal
|
June 29, 2007
Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
L J van der Giessen, R Gosselink, W C J Hop, et al.
Journal of Theoretical Biology
|
March 10, 2015
Model of mucociliary clearance in cystic fibrosis lungs
P Kurbatova, N Bessonov, V Volpert, et al.
European Journal of Medical Genetics
|
January 4, 2011
Lung disease in FLNA mutation: confirmatory report
M C Y de Wit, H A W M Tiddens, I F M de Coo, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
January 24, 2012
Determining presence of lung disease in young children with cystic fibrosis: lung clearance index, oxygen saturation and cough frequency
E M Bakker, J C van der Meijden, E M Nieuwhof, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
February 24, 2006
[Fatal asthma in childhod preventable by recognizing risk factors and presenting features]
S C A T Verbruggen, L J A Corel, H A W M Tiddens, et al.
Page
of 3